Kidney transplantation is an obvious candidate for value based purchasing initiatives, aimed at improving quality and reducing costs of kidney transplant care in the United States. There is wide variation in quality, a large, single payer (CMS), and high quality data uniquely suited for profiling kidney transplant center quality. Unfortunately, the potential for value based purchasing to increase quality and reduce costs is limited by a lack of good measures. With respect to quality, the simple outcome measures that are currently used, such as graft function and mortality, may not reliably reflect a hospitals true performance and may be difficult to interpret. An empirically derived composite measure may overcome these limitations, but such a measure has not yet been developed. With this proposal, we will develop a composite measure of quality for kidney transplantation. Completing this aim will require the development of novel techniques to assess transplant center quality, and we propose to use empirical Bayes methods to develop a composite measure of one-year graft function. In addition to identifying high quality hospitals, payers are, of course, interested in constraining costs. For this reason, a better understanding of the relationship between quality and costs is critical in optimizing quality measures for value-based purchasing strategies. Thus, in this proposal we will develop a better understanding of the relationship between quality and costs in kidney transplantation. Specifically, we will assess how our composite measure of transplant center quality relates to transplant center Medicare payments for kidney transplant care.
This research has significant implications for public health, in general. Better quality measures could be invaluable in reforming payment systems, fostering accountability, and improving the care of patients undergoing kidney transplantation in the United States. Moreover, we hope that this work will provide the framework for effective value-based purchasing initiatives in kidney transplantation.
|Sheetz, Kyle H; Waits, Seth A; Girotti, Micah E et al. (2014) Patients' perspectives of care and surgical outcomes in Michigan: an analysis using the CAHPS hospital survey. Ann Surg 260:5-9|
|Lee, Christopher S; Cron, David C; Terjimanian, Michael N et al. (2014) Dorsal muscle group area and surgical outcomes in liver transplantation. Clin Transplant 28:1092-8|
|Miller, Ashley L; Min, Lillian C; Diehl, Kathleen M et al. (2014) Analytic morphomics corresponds to functional status in older patients. J Surg Res 192:19-26|
|Krell, Robert W; Kaul, Daniel R; Martin, Andrew R et al. (2013) Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 19:1396-402|
|Sheetz, Kyle H; Waits, Seth A; Terjimanian, Michael N et al. (2013) Cost of major surgery in the sarcopenic patient. J Am Coll Surg 217:813-8|
|Englesbe, Michael J; Terjimanian, Michael N; Lee, Jay S et al. (2013) Morphometric age and surgical risk. J Am Coll Surg 216:976-85|
|Smith, Margaret; Hussain, Adnan; Xiao, Jane et al. (2013) The importance of improving the quality of emergency surgery for a regional quality collaborative. Ann Surg 257:596-602|
|Lee, Jay S; Terjimanian, Michael N; Tishberg, Lindsay M et al. (2011) Surgical site infection and analytic morphometric assessment of body composition in patients undergoing midline laparotomy. J Am Coll Surg 213:236-44|
|Englesbe, M J; Sung, R S; Segev, D L (2011) Young transplant surgeons and NIH funding. Am J Transplant 11:245-52|
|Waits, Seth A; Wojcik, Brandon M; Cai, Shijie et al. (2011) Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States. Liver Transpl 17:1066-72|
Showing the most recent 10 out of 13 publications